Elo Mutual Pension Insurance Co lessened its holdings in Centene Co. (NYSE:CNC – Free Report) by 6.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 53,878 shares of the company’s stock after selling 3,759 shares during the quarter. Elo Mutual Pension Insurance Co’s holdings in Centene were worth $3,264,000 as of its most recent SEC filing.
A number of other hedge funds also recently made changes to their positions in CNC. Harris Associates L P increased its stake in Centene by 5.7% in the third quarter. Harris Associates L P now owns 26,314,183 shares of the company’s stock valued at $1,980,932,000 after acquiring an additional 1,420,825 shares during the period. State Street Corp grew its stake in shares of Centene by 0.5% in the 3rd quarter. State Street Corp now owns 23,468,159 shares of the company’s stock valued at $1,766,683,000 after purchasing an additional 111,654 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Centene by 3.5% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,768,534 shares of the company’s stock worth $434,255,000 after buying an additional 194,566 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Centene by 3.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,803,437 shares of the company’s stock valued at $230,412,000 after buying an additional 130,895 shares in the last quarter. Finally, Hotchkis & Wiley Capital Management LLC grew its position in Centene by 15.4% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 3,203,049 shares of the company’s stock valued at $241,126,000 after acquiring an additional 428,100 shares during the period. Institutional investors and hedge funds own 93.63% of the company’s stock.
Analysts Set New Price Targets
A number of research analysts have issued reports on CNC shares. Stephens cut their price objective on Centene from $75.00 to $73.00 and set an “equal weight” rating for the company in a report on Friday, December 13th. Wells Fargo & Company reduced their price target on shares of Centene from $76.00 to $72.00 and set an “overweight” rating on the stock in a research report on Friday, February 14th. Barclays raised their price objective on shares of Centene from $91.00 to $93.00 and gave the stock an “overweight” rating in a report on Friday, December 13th. JPMorgan Chase & Co. restated an “overweight” rating and set a $75.00 price target (down from $80.00) on shares of Centene in a research report on Tuesday, December 17th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $90.00 price objective on shares of Centene in a research report on Wednesday, December 11th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $79.92.
Centene Stock Down 0.5 %
NYSE:CNC opened at $59.96 on Friday. The stock’s fifty day simple moving average is $59.94 and its 200-day simple moving average is $62.79. The firm has a market capitalization of $29.74 billion, a P/E ratio of 9.61, a P/E/G ratio of 0.80 and a beta of 0.40. The company has a quick ratio of 1.10, a current ratio of 1.11 and a debt-to-equity ratio of 0.70. Centene Co. has a 12-month low of $55.03 and a 12-month high of $80.59.
Centene (NYSE:CNC – Get Free Report) last posted its earnings results on Tuesday, February 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.49 by $0.31. The company had revenue of $40.81 billion during the quarter, compared to analyst estimates of $38.78 billion. Centene had a return on equity of 13.85% and a net margin of 2.03%. The company’s revenue for the quarter was up 3.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.45 EPS. Equities research analysts expect that Centene Co. will post 6.86 earnings per share for the current year.
About Centene
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Further Reading
- Five stocks we like better than Centene
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Insider Trades May Not Tell You What You Think
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- 3 REITs to Buy and Hold for the Long Term
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.